Here's the live share price of Wanbury along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Wanbury | -3.63 | -11.16 | -3.97 | 2.04 | -11.10 | 64.80 | 25.54 |
| Sun Pharmaceutical Industries | -1.10 | -3.11 | 6.72 | 8.55 | 20.01 | 19.65 | 19.36 |
| Divi's Laboratories | -1.82 | 8.71 | 37.99 | 44.45 | 48.31 | 35.81 | 11.82 |
| Torrent Pharmaceuticals | -3.67 | -3.58 | 11.81 | 11.70 | 34.86 | 38.43 | 25.38 |
| Zydus Lifesciences | -5.56 | 0.22 | 3.28 | 25.03 | 10.77 | 21.79 | 15.02 |
| Cipla | -2.33 | -4.48 | -0.91 | 5.51 | -12.21 | 3.79 | 7.82 |
| Laurus Labs | -4.92 | 0.25 | 28.92 | 78.60 | 110.67 | 67.07 | 22.74 |
| Lupin | -2.94 | -11.15 | -6.12 | -8.39 | 8.85 | 24.38 | 16.53 |
| Dr. Reddy's Laboratories | -2.02 | -0.57 | -8.92 | -10.62 | -7.93 | 0.64 | 3.26 |
| Mankind Pharma | -2.47 | -5.38 | -1.10 | 5.62 | -9.26 | 9.97 | 10.33 |
| Aurobindo Pharma | 0.20 | 4.39 | 12.96 | 38.34 | 59.70 | 26.36 | 16.97 |
| Glenmark Pharmaceuticals | -3.59 | 9.37 | 11.26 | 18.96 | 21.92 | 47.18 | 35.27 |
| Biocon | -3.44 | -6.56 | -4.44 | 5.02 | 11.31 | 15.01 | 1.91 |
| Alkem Laboratories | -3.06 | -5.70 | -1.70 | -5.03 | -2.22 | 12.43 | 6.28 |
| Abbott India | -0.66 | -6.19 | 1.11 | -6.10 | -18.87 | 5.35 | 5.90 |
| Anthem Biosciences | 3.26 | 13.61 | 24.74 | 39.49 | 10.19 | 8.39 | 4.95 |
| GlaxoSmithKline Pharmaceuticals | -4.60 | 11.93 | 36.77 | 19.37 | 4.32 | 27.64 | 14.60 |
| Ipca Laboratories | 0.73 | 16.81 | 21.30 | 33.12 | 46.83 | 30.68 | 9.48 |
| Gland Pharma | 1.61 | 13.62 | 32.04 | 71.54 | 55.38 | 19.73 | -5.98 |
| Ajanta Pharma | -2.66 | -1.64 | 17.53 | 18.80 | 33.18 | 26.31 | 18.64 |
Source: Dion Global
Over the last one year, Wanbury has declined 11.10% compared to peers like Sun Pharmaceutical Industries (20.01%), Divi's Laboratories (48.31%), Torrent Pharmaceuticals (34.86%). From a 5 year perspective, Wanbury has outperformed peers relative to Sun Pharmaceutical Industries (19.36%) and Divi's Laboratories (11.82%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 253.25 | 252.97 |
| 10 | 259.7 | 256.96 |
| 20 | 258.82 | 263.95 |
| 50 | 285.66 | 273.87 |
| 100 | 274.76 | 271.77 |
| 200 | 255.54 | 263.99 |
Source: Dion Global
In the latest quarter, Wanbury remained same as its previous close in promoter holding, while DII stake increased to 0.06%, FII holding rose to 0.89%, and public shareholding moved down to 56.04% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Sep 01, 2026, 12:32 AM IST IST | Wanbury - Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM). |
| Sep 01, 2026, 12:17 AM IST IST | Wanbury - Reg. 34 (1) Annual Report. |
| Sep 01, 2026, 12:06 AM IST IST | Wanbury - Annual Report 2025-26 And Notice Of The 38Th Annual General Meeting Of Wanbury Limited. |
| Aug 13, 2026, 06:18 AM IST IST | Wanbury - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 12, 2026, 02:45 AM IST IST | Wanbury - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Source: Dion Global
Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 650.27 Cr. and Equity Capital is Rs. 34.94 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Wanbury is ₹247.95 as on Sep 04, 2026.
The Wanbury is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Wanbury is ₹867.00 Cr as on Sep 04, 2026.
Today’s highest and lowest price of Wanbury are ₹248.05 and ₹242.95.
The 52-week high/low is the highest and lowest price at which Wanbury stock has traded in the past 52-week or nearly a year. The 52-week high of Wanbury is ₹360.00 and 52-week low of Wanbury is ₹162.00 as on Sep 04, 2026.
The Wanbury has shown returns of 1.62% over the past day, -11.16% for the past month, -3.97% over 3 months, -11.1% over 1 year, 64.8% across 3 years, and 25.54% over 5 years.
P/E ratio of and PB ratio of Wanbury are 20.17 and 21.17 on Sep 04, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global